New research from the Howard Florey Institute in Melbourne has shown why mutation in a single gene can cause epilepsy in infants.
Infants are more susceptible to seizures because their brains are developing at a rapid rate, making their brain cells ‘excitable’. Their neurons are growing and making new connections with other nerve cells, which can disrupt normal brain activity and results in epilepsy.
Infants have protective mechanisms in their brains to control this excitability, but now the Florey scientists have uncovered that a single gene mutation prevents a specific ion channel from functioning correctly, thus causing excitability which results in epilepsy.
Dr Steven Petrou and his team knew the genetic mutation existed, but did not know its impact on brain function or that it may control excitability in infants’ brains.
“This discovery is helping us to understand how and why this form of epilepsy, known as benign familial neonatal-infantile seizures, appears in these infants,” Dr Petrou said.
“Interestingly, we also found that the ion channel which carries the mutation is itself naturally protective as it limits excitability in the infant brain by waiting to fully ‘switch on’ only in the adult brain.
“The mutation accelerates this normally delayed development change, leaving the susceptible infant brain with an overly excitable channel and epilepsy.
“If this switch to a more excitable state occurs too early during brain development, it is possible that epilepsy and other neurological disorders develop.
“This highlights the complexity of the human brain and how disorders can develop if one single mechanism goes awry,” he said.
This research was recently published in Molecular and Cellular Neuroscience. According to Dr Petrou, potential new avenues of research may emerge from this study.
Epilepsy affects 3% of the Australian population and better treatments are urgently needed as many existing therapies have serious side-effects for patients. In 30% of cases, the current drug options available provide limited seizure relief.
There are more than 200 types of epilepsy, which can either be inherited or result from a range of causes including, head trauma, vascular disease or brain tumours.
Source: Research Australia
Related stories:
Scientists trace extensive networks regulating alternative RNA splicing
RNA targets of tissue-specific splicing factors Fox-1 and Fox-2 are successfully predicted
Two professors at Cold Spring Harbor Laboratory (CSHL) have succeeded in tracing intricate biochemical networks involving a class of proteins that enable genes to express themselves in specific tissues at particular moments in development.
Drug reverses mental retardation caused by genetic disorder
UCLA mouse study offers hope for correcting how autism disrupts brain
UCLA researchers discovered that an FDA-approved drug reverses the brain dysfunction inflicted by a genetic disease called tuberous sclerosis complex (TSC). Because half of TSC patients also suffer from autism, the findings offer new hope for addressing learning disorders due to autism.
Nature Medicine publishes the findings in its online June 22 edition.
Scientists identify genetic cause for a type of childhood epilepsy
Imagine “blanking out” of consciousness up to 200 times daily while you’re learning in a classroom, playing baseball, taking ballet lessons or riding a bike. This is a common occurrence in the life of a child with childhood absence epilepsy (CAE). The condition is associated with frequent “absent” seizures where the patient’s consciousness is impaired leaving the child staring blankly ahead not aware or responsive for up to 10 seconds at a time.
Mutant gene causes epilepsy, intellectual disability in women
A mutated gene has been discovered as the key behind epilepsy and mental retardation specific to women, thanks to new research at Adelaide’s Women’s & Children’s Hospital and the University of Adelaide, Australia.
Researchers uncover mechanism of action of antibiotic able to reduce neuronal cell death in brain
Virginia Commonwealth University researchers have discovered how an antibiotic works to modulate the activity of a neurotransmitter that regulates brain functions, which eventually could lead to therapies to treat Alzheimer’s disease, Huntington’s disease, epilepsy, stroke, dementia and malignant gliomas.
With just 3 affected individuals, researchers find gene behind rare form of epilepsy
Researchers have found a gene responsible for a particularly debilitating form of epilepsy that also leads to kidney failure, according to a report published online on February 28th and also in the March 7th print issue of the
American Journal of Human Genetics, a publication of Cell Press. What’s more, the new findings, which begin to “crack open the cell biology of the problem,” were made with the help of just three affected individuals.
Fragile X retardation syndrome corrected in mice
Researchers working with mice have significantly alleviated a wide range of abnormalities due to fragile X syndrome by altering only a single gene, countering the effects of the fragile X mutation. They said their achievement offers the potential for treatment of the disorder, the most common form of inherited mental retardation and a leading identified genetic cause of autism. There is currently no treatment or therapy for fragile X syndrome, whose symptoms include mental retardation, epilepsy, and abnormal body growth.
Epilepsy genes may cancel each other
Inheriting two genetic mutations that can individually cause epilepsy might actually be “seizure-protective,” said Baylor College of Medicine researchers in a report that appears online today in the journal
Nature Neuroscience.